Hepatitis B virus (HBV) genotype distribution and lamivudine-resistant mutations in HIV/HBV co-infected patients attending a Parisian hospital
Nathalie Schnepf(Assistance Publique – Hôpitaux de Paris), M.C. Mazeron(Hôpital Lariboisière), Guy G. Simoneau(Hôpital Fernand-Widal), Aldo Trylesinski(Novartis (Switzerland)), Inmaculada Jarrín(Instituto de Salud Carlos III), Carmelo Lafuente‐Lafuente(Assistance Publique – Hôpitaux de Paris), JD Magnier(Hôpital Lariboisière), Pierre Sellier(Inserm)
Cited by 0
Related Papers
Life expectancy after 2015 of adults with HIV on long-term antiretroviral therapy in Europe and North America: a collaborative analysis of cohort studies
|The Lancet HIV|2023|506
Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy
|Annals of Internal Medicine|2020|342
Origin, HDV genotype and persistent viremia determine outcome and treatment response in patients with chronic hepatitis delta
|Journal of Hepatology|2020|151
Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19)
|Clinical Microbiology and Infection|2020|128
Effect Estimates in Randomized Trials and Observational Studies: Comparing Apples With Apples
|American Journal of Epidemiology|2019|116